Introduction {#sec1-1}
============

Hypertension is a known risk factor for cerebrovascular disease, cardiac disease, chronic kidney disease, peripheral vascular disease, cognitive impairment, and premature death. If left untreated, hypertension can cause a progressive increase in blood pressure (BP), often resulting in a treatment-resistant condition due to vascular and renal damage.\[[@ref1]\]

According to the newly released guidelines published by the American Heart Association, the American College of Cardiology, and nine other societies, the hypertension threshold has been lowered from systolic BP 140 mmHg/diastolic BP 90 mmHg to systolic BP 130 mmHg/diastolic BP 80 mmHg, resulting in a new diagnosis in approximately 14% more Americans.\[[@ref2]\]

Kearney *et al*.\'s 2005 paper, "Global burden of hypertension: analysis of worldwide data" projected a 60% increase in the number of adults with hypertension to a total of 1.56 billion by 2025.\[[@ref3]\] A population-based study in Saudi Arabia reported a prevalence of prehypertension as 66.1%, 48.1%, and 54.9% in males, females, and all participants, respectively, whereas the prevalence of hypertension was 6.0%, 4.2%, and 4.9% in males, females, and all participants, respectively.\[[@ref4]\]

Nonadherence to medication is of growing concern and is associated with adverse outcomes.\[[@ref5]\] Few studies have been published in Saudi Arabia on the compliance of hypertensive patients. A study in Tabuk, Saudi Arabia, which focused on drug compliance of hypertensive patients concluded that the compliance rate was 53.0%.\[[@ref6]\] Another study on the compliance and knowledge of hypertensive patients attending Primary Health-Care clinic (PHCC) centers in AL-Khobar, Saudi Arabia, found the overall compliance rate to be 34.2%.\[[@ref7]\]

Long-term noncompliance to therapy severely jeopardizes the efficacy of treatment and adversely affects the condition of the patient.\[[@ref8]\]

Materials and Methods {#sec1-2}
=====================

A cross-sectional quantitative design was used to carry out this study over a period of 10 months from January 2018 to October 2018. At the National Guard-Health Affairs (NGHA) PHCC, Dammam, Saudi Arabia, The number of hypertensive patients attending the PHCC is approximately 1810/year. The population of the study consisted of hypertensive patients on antihypertensive treatment and who attended PHCC in Dammam. Assuming the population proportion as 0.5, confidence level as 95%, and a margin of error of 0.05, the required sample size was calculated as 402.\[[@ref9][@ref10]\]

The participants for the study were selected using a convenience sampling procedure because it is quick, is inexpensive, and is convenient.\[[@ref11]\] Detection of hypertensive patients took place in the triage room while vital signs were being taken. The nurse selected known hypertensive patients and sent them to the principal investigator and/or the co-investigators to be interviewed and complete the questionnaire. Before the completion of the questionnaire, the participant was asked if he/she had ever been interviewed to avoid any duplication. Using formal questionnaires, the data were collected. The questions, structured according to the Health Belief Model (HBM)-based research goals, highlighted patients\' sociodemographic characteristics; perception of severity; their views on sensitivity, benefits, barriers; and cues to action.

The validity of the questionnaire was examined by the team\'s internist for clarity and specificity of variables. A pretest or pilot test was conducted on 10% of the sample who were then excluded from the real sample of the study. This test was to discover any unclear questions that needed rewording or deletion. Reliability coefficient was, however, not calculated.

Included in the study were patients aged 18 years or more who had received antihypertensive treatment for at least 1 month. Excluded were those \<18 years of age and those who were unable to respond to interviews (e.g., patients who were very sick).

The outcome variable was compliance with treatment, which consists of compliance with the drug regimen and lifestyle changes. The evaluation of medication regimen compliance was included in the questionnaire comprising seven items. The HBM variables evaluating the perception of hypertension severity, perception of susceptibility to complications of hypertension, perception of barriers and benefits, and cues to action were also in the questionnaire.

Data were entered into the computer and analyzed using Microsoft Excel version 10, and then transferred to SPSS software. The data were summarized using frequency tables to determine the findings of the data, including frequencies and percentages. Cross tabulations were conducted between variables and demographic characteristics. The Chi-square test was used to compare ratios, and a Pearson\'s correlation analysis of HBM variables was carried out. *P* ≤ 0.05 was considered statistically significant.

Compliance with antihypertensive drugs was the dependent variable. Independent variables included sociodemographic characteristics and HBM variables including perceived severity of hypertension, susceptibility to complications of hypertension, benefits of compliance to treatment, barriers to compliance, and cues to action for treatment compliance.

Permission was obtained from the Institutional Review Board of King Abdullah International Medical Research Center to conduct the study. Strict ethical standards and procedures were followed. Participation in the study was entirely voluntary, and permission was obtained from the patients to participate in the study. Informed consent was obtained in writing before interviewing patients. All information obtained was kept strictly confidential, and participants were assured about anonymity. Prior to giving consent, information about the principal investigator was given to the participants, and the purpose of the research was explained to them.\[[@ref12]\]

Results {#sec1-3}
=======

Participating in the study were a total of 402 patients comprising 198 males (49%) and 204 females (51%) aged 18 to 70+ years, with 54.09 (±10.7) years of mean age (±standard deviation \[SD\]). Their sociodemographic features are shown in [Table 1](#T1){ref-type="table"}. Of the participants, 16% had no formal education, 24% had primary school education, 32% had secondary school education, and 27% had graduated from college. Nearly 79% of the participants were married, and 18% were widowed. Half of the participants had no employment, while the other 50% were employed, of which most (26%) were government employees, 15% were nongovernmental employees, and 9% were businesspeople.

###### 

Respondents' social and demographic characteristics (*n*=402)

  Characteristics             Number (%)
  --------------------------- ------------
  Age (years)                 
   18-40                      40 (10.0)
   41-50                      129 (32.0)
   51-60                      124 (31.0)
   61-70                      77 (19.0)
   70+                        32 (8.0)
  Sex                         
   Male                       198 (49.0)
   Female                     204 (51.0)
  Marital status              
   Single                     6 (1.0)
   Married                    319 (79.0)
   Divorced                   5 (1.0)
   Widow                      72 (18.0)
  Level of education          
   No formal education        65 (16.0)
   Primary school             97 (24.0)
   High school                128 (32.0)
   College and postgraduate   112 (28.0)
  Occupation                  
   Government                 104 (26.0)
   Nongovernmental            60 (15.0)
   Businessperson             32 (9.0)
   Unemployed                 201 (50.0)

[Table 2](#T2){ref-type="table"} shows the compliance with antihypertensive medications in relation to gender; 58.8% of the females were compliant, while 41.2% were noncompliant. With respect to males, 19.7% were compliant and 80.3% were noncompliant, clearly showing that females were more compliant than males. The relation between participant\'s age and compliance with medication regimen is also shown in [Table 2](#T2){ref-type="table"}. The proportion of participants who complied with treatment was 159 (39.6%); 32 (20%) of them were in the age group of 56--60 years and had better compliance with antihypertensives than those in the other age groups. While the proportion of participants who did not comply to treatment was 243 (60.4%), 57 (23.5%) of them were aged 46--50 and they were least compliant to antihypertensive treatment with *P* = 0.002. Compliance with antihypertensive medications in relation to HBM variables is also exhibited in [Table 3](#T3){ref-type="table"} with *P* \< 0.05.

###### 

Compliance to antihypetensive medication by gender, age, and HBM variables

                                 Noncompliance *N* (%)   Compliance *N* (%)   Total *N* (%)   *P*-Value
  ------------------------------ ----------------------- -------------------- --------------- -----------
  Gender                                                                                      
   Male                          159 (80.3)              39 (19.7)            198 (100)       \<0.001
   Female                        84 (41.2)               120 (58.8)           204 (100)       
  Age groups                                                                                  
   18-40                         31 (12.7)               9 (5.6)              40 ((18.3)      0.002
   41-50                         91 (37.5)               38 (23.9)            129 (32.1)      
   51-60                         69 (28.4)               55 (34.6)            124 (30.9)      
   61-70                         39 (16.1)               38 (23.9)            77 (19.1)       
   70+                           13 (5.3)                19 (11.9)            32 (8.0)        
  Perception of severity         210 (52.2)              192 (47.8)           402 (100)       \<0.05
  Perception of susceptibility   245 (60.9)              157 (39.1)           402 (100)       
  Perception of benefits         189 (47.0)              213 (53.0)           402 (100)       
  Perception of barriers         234 (58.2)              168 (41.8)           402 (100)       
  Cues to action                 206 (51.2)              196 (48.8)           402 (100)       

HBM: Health Belief Model

###### 

Pearson's correlation between Health Belief Model variables

                             Treatment compliance   Perceived severity   Perceived susceptibility   Perceived benefit   Perceived barrier   Cues to action
  -------------------------- ---------------------- -------------------- -------------------------- ------------------- ------------------- ----------------
  Treatment compliance       1.0                    −0.090               0.125\*                    0.108\*             0.134\*\*           0.149\*\*
  Perceived severity                                1.0                  0.257\*\*                  0.149\*\*           0.019               −0.061
  Perceived susceptibility                                               1.0                        0.317\*\*           0.183\*\*           −0.014
  Perceived benefit                                                                                 1.0                 0.120\*             0.056
  Perceived barrier                                                                                                     1.0                 0.110\*
  Cues to action                                                                                                                            1.0

\*\**P*=0.01 level, \**P*=0.05 level

[Table 3](#T3){ref-type="table"} shows the Pearson\'s correlation between HBM variables.

Compliance with the treatment showed a significant positive relation with perceived susceptibility (*r* = 0.125; *P* = 0.05), indicating that the higher the perceived susceptibility to complications with hypertension, the better the compliance. Compliance to treatment showed a positive relation with perceived benefit (*r* = 0.108; *P* = 0.05), indicating that the higher the perceived benefit of the use of medication, the better the compliance. Compliance with treatment showed a positive relation with perceived treatment barriers (*r* = 0.134; *P* = 0.01), indicating that the higher the perceived treatment barriers, the higher the compliance. Compliance with treatment also showed a positive relation with cues to action (*r* = 0.149; *P* = 0.01), indicating that the higher the cues to action, the higher the compliance.

Perceived severity showed a positive relation with perceived susceptibility (*r* = 0.257; *P* = 0.01), indicating that the higher the perceived severity of the disease, the greater the perception of vulnerability to complications. The perceived severity showed a positive relation with the perceived benefit (*r* = 0.149; *P* = 0.01), indicating that the higher the perceived severity, the greater the perceived benefit of taking medication.

Perceived susceptibility showed a positive relation with the perceived benefit of using drugs (*r* = 0.317; *P* = 0.01), indicating that the higher the perceived susceptibility of having complications of hypertension, the higher the perceived benefit of using medication. Perceived susceptibility showed a positive relation with perceived treatment barriers (*r* = 0.183; *P* = 0.01), indicating that the higher the perceived susceptibility to complications of hypertension, the higher the perceived treatment barriers.

Perceived benefit showed a positive relation with perceived barriers to treatment (*r* = 0.120; *P* = 0.05), indicating that the higher the perceived barriers to treatment, the higher the perceived benefit of taking medication.

Perceived barriers showed a positive relation with cues to action (*r* = 0,110; *P* = 0.05), indicating that the higher the perceived barriers to treatment, the higher following the cues to action (reminders).

Discussion {#sec1-4}
==========

This study evaluated and explored factors affecting treatment compliance to antihypertensive therapy by hypertensive patients attending the NGHA PHCC, Dammam. This was a quantitative cross-sectional study, and the data were gathered using questions developed in accordance with research goals in formal questionnaires. Compliance to medication regimen was 39.6%, which was less than the results obtained at Tabuk, Saudi Arabia, by Khalil *et al*. in May 1997, in which the compliance rate was found to be 53.0%.\[[@ref13]\]

The study showed that participants aged 56--60 years were better at complying to treatment (20.1%) than those \>60 years of age and \<56 years of age. These results are comparable to those reported in the February 2018 study by Dedefo and Berisa in Ethiopia, which showed that adherence was more likely to occur among those \>55 years of age.\[[@ref14]\]

The findings of this study showed that 58.8% of females were compliant, whereas only 19.7% of males were compliant, clearly showing that females were more compliant to treatment than males. This is comparable to the study carried out in September 2017 by Tibebu *et al*. which concluded that females were better at adhering to instructions on medication than males.\[[@ref15]\]

This study also assessed the relationship between HBM variables and treatment compliance and showed a significant positive association with all HBM variables. Consequently, it is highly recommended that counseling and health education should be regularly given to hypertensive patients whenever they attend clinics for routine follow-up.

Nonadherence to medication is of growing concern and is associated with adverse outcomes. Maintaining medication adherence to multiple medications is a complex issue in patients with chronic diseases, particularly cardiovascular diseases. The most important cause of uncontrolled BP is the impact of nonadherence to antihypertensive medications. As a result, most (nearly three quarters) of the hypertensive patients do not achieve optimal control of BP.\[[@ref16]\]

This study was conducted in the NGHA PHCC, Dammam; therefore, the results cannot be generalized to all patients with hypertension. However, the results provided important information on what patients believe about hypertension and its complications, which may resemble other NGHA facilities.

The convenience sampling method used to select the study participants is highly vulnerable to selection bias and influences beyond the control of the researcher, as well as high levels of sampling error and low credibility.\[[@ref17]\] However, this method was employed because it is fast, simple, readily available, and cost-effective.\[[@ref18]\] Furthermore, because of the large number of hypertensive patients attending the clinics, a simple random sampling procedure is difficult to implement.

Conclusions and Recommendations {#sec1-5}
===============================

In this study, compliance rate with antihypertensive treatment was 39.6%. The mean age (±SD) of the study participants was 54.09 (±10.703) years. Compliance with medication schemes, lifestyle changes, perceived severity, perceived susceptibility, perceived benefits, and perceived barriers was statistically significant (*P* \< 0.05) based on Pearson\'s correlation and Chi-square test.

Based on the results of this study, it is recommended that regular counseling and health education be given to hypertensive patients whenever they attend routine follow-up clinics.
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